Research programme: vascular disorder theapeutics - Sardocor
Latest Information Update: 20 Oct 2023
At a glance
- Originator Sardocor
- Class Gene therapies; Vascular disorder therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Arteriovenous fistula; Restenosis
Most Recent Events
- 11 Oct 2023 Preclinical trials in Arteriovenous fistula in USA (Intra-arterial) before October 2023 (Sardocor pipeline, October 2023)
- 11 Oct 2023 Preclinical trials in Arteriovenous fistula in USA (IV) before October 2023 (Sardocor pipeline, October 2023)
- 11 Oct 2023 Preclinical trials in Restenosis in USA (Intra-arterial) before October 2023 (Sardocor pipeline, October 2023)